AU2020235344B2 - Norovirus-like particles with improved stability - Google Patents

Norovirus-like particles with improved stability Download PDF

Info

Publication number
AU2020235344B2
AU2020235344B2 AU2020235344A AU2020235344A AU2020235344B2 AU 2020235344 B2 AU2020235344 B2 AU 2020235344B2 AU 2020235344 A AU2020235344 A AU 2020235344A AU 2020235344 A AU2020235344 A AU 2020235344A AU 2020235344 B2 AU2020235344 B2 AU 2020235344B2
Authority
AU
Australia
Prior art keywords
pro
leu
val
gly
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2020235344A
Other languages
English (en)
Other versions
AU2020235344A1 (en
Inventor
André DIESSNER
Franziska Jarczowski
Frank Thieme
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icon Genetics AG
Original Assignee
Icon Genetics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icon Genetics AG filed Critical Icon Genetics AG
Publication of AU2020235344A1 publication Critical patent/AU2020235344A1/en
Application granted granted Critical
Publication of AU2020235344B2 publication Critical patent/AU2020235344B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2020235344A 2019-03-12 2020-03-11 Norovirus-like particles with improved stability Active AU2020235344B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19162266 2019-03-12
EP19162266.1 2019-03-12
PCT/EP2020/056461 WO2020182860A1 (en) 2019-03-12 2020-03-11 Norovirus-like particles with improved stability

Publications (2)

Publication Number Publication Date
AU2020235344A1 AU2020235344A1 (en) 2021-09-23
AU2020235344B2 true AU2020235344B2 (en) 2024-10-24

Family

ID=65818179

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020235344A Active AU2020235344B2 (en) 2019-03-12 2020-03-11 Norovirus-like particles with improved stability

Country Status (10)

Country Link
US (1) US20220152186A1 (https=)
EP (1) EP3938378B1 (https=)
JP (2) JP7536031B2 (https=)
KR (1) KR20220021451A (https=)
CN (1) CN113557240B (https=)
AU (1) AU2020235344B2 (https=)
ES (1) ES2953232T3 (https=)
IL (1) IL285914B2 (https=)
MX (1) MX2021011059A (https=)
WO (1) WO2020182860A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020235344B2 (en) * 2019-03-12 2024-10-24 Icon Genetics Gmbh Norovirus-like particles with improved stability
US20250002539A1 (en) * 2021-07-26 2025-01-02 The University Of North Carolina At Chapel Hill Methods and compositions for norovirus chimeric therapeutics
CN118252924A (zh) * 2022-12-27 2024-06-28 远大赛威信生命科学(南京)有限公司 用于诱发哺乳动物针对诺如病毒的免疫反应的药物组合物及其制备方法和用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3153578A1 (en) * 2010-07-06 2017-04-12 Novartis Ag Norovirus derived immunogenic compositions and methods
WO2018170603A1 (en) * 2017-03-23 2018-09-27 Medicago Inc. Norovirus fusion proteins and vlps comprising norovirus fusion proteins

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1025234A1 (en) 1997-10-24 2000-08-09 E.I. Du Pont De Nemours And Company Binary viral expression system in plants
EP1115870A2 (en) 1998-09-23 2001-07-18 E.I. Du Pont De Nemours And Company Binary viral expression system in plants
DE10109354A1 (de) 2001-02-27 2002-09-05 Icon Genetics Ag Rekombinante virale Schaltersysteme
DE10121283B4 (de) 2001-04-30 2011-08-11 Icon Genetics GmbH, 80333 Verfahren und Vektoren zur Amplifikation oder Expression von gewünschten Nucleinsäuresequenzen in Pflanzen
CN1533438A (zh) 2001-06-08 2004-09-29 �����Ŵ��Ƽ���˾ 在植物生产蛋白质的方法
AU2002314021B2 (en) 2002-04-30 2008-04-10 Icon Genetics Gmbh Amplification vectors based on trans-splicing
WO2006012906A1 (en) 2003-11-10 2006-02-09 Icon Genetics Ag Rna virus-derived plant expression system
ATE469231T1 (de) 2003-11-10 2010-06-15 Icon Genetics Gmbh Von rna-virus abgeleitetes pflanzenexpressionssystem
EP1564295A1 (en) 2004-01-23 2005-08-17 Icon Genetics AG RNA virus-derived plant expression system
EP1616959A1 (en) 2004-07-07 2006-01-18 Icon Genetics AG Biological safe transient protein expression in plants
CA2648886C (en) 2006-05-29 2015-10-20 Icon Genetics Gmbh Plant virus-based inducible expression system
EP1897953A1 (en) 2006-09-06 2008-03-12 Icon Genetics GmbH Potexvirus-derived replicon
SG10202012986SA (en) 2006-09-29 2021-01-28 Ligocyte Pharmaceuticals Inc Norovirus vaccine formulations
JP5846908B2 (ja) * 2009-05-28 2016-01-20 東洋紡株式会社 特性の改変されたグルコースデヒドロゲナーゼ
EP2418283A1 (en) 2010-08-07 2012-02-15 Nomad Bioscience GmbH Process of transfecting plants
EP2647715A1 (en) 2012-04-03 2013-10-09 Nomad Bioscience GmbH Agrobacterium for transient transfection of whole plants
JOP20130186B1 (ar) 2012-06-22 2021-08-17 Takeda Vaccines Montana Inc تنقية الجزيئات الشبيهة بالفيروسات
CA2913068C (en) 2013-05-23 2023-01-10 Nomad Bioscience Gmbh Process of providing plants with abiotic stress resistance
US11208441B2 (en) * 2015-10-22 2021-12-28 Protenova Co., Ltd. Immunoglobulin-binding polypeptide
AU2020235344B2 (en) * 2019-03-12 2024-10-24 Icon Genetics Gmbh Norovirus-like particles with improved stability

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3153578A1 (en) * 2010-07-06 2017-04-12 Novartis Ag Norovirus derived immunogenic compositions and methods
WO2018170603A1 (en) * 2017-03-23 2018-09-27 Medicago Inc. Norovirus fusion proteins and vlps comprising norovirus fusion proteins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Y. SOMEYA ET AL: "Assembly of homogeneous norovirus-like particles accomplished by amino acid substitution", JOURNAL OF GENERAL VIROLOGY., vol. 92, no. 10, 29 June 2011, pages 2320 - 2323, DOI: 10.1099/vir.0.033985-0 *

Also Published As

Publication number Publication date
EP3938378A1 (en) 2022-01-19
EP3938378C0 (en) 2023-08-02
IL285914A (en) 2021-10-31
JP2022522891A (ja) 2022-04-20
CN113557240B (zh) 2025-02-25
MX2021011059A (es) 2021-10-13
CA3133030A1 (en) 2020-09-17
AU2020235344A1 (en) 2021-09-23
JP7672460B2 (ja) 2025-05-07
EP3938378B1 (en) 2023-08-02
JP7536031B2 (ja) 2024-08-19
WO2020182860A1 (en) 2020-09-17
IL285914B1 (en) 2024-07-01
JP2024009801A (ja) 2024-01-23
US20220152186A1 (en) 2022-05-19
CN113557240A (zh) 2021-10-26
KR20220021451A (ko) 2022-02-22
IL285914B2 (en) 2024-11-01
ES2953232T3 (es) 2023-11-08

Similar Documents

Publication Publication Date Title
KR102199018B1 (ko) 식물에서 인플루엔자 바이러스-유사 입자 생산
AU2020235344B2 (en) Norovirus-like particles with improved stability
JP6297488B2 (ja) 植物中での狂犬病ウイルス様粒子の生成
US20250122549A1 (en) Influenza virus hemagglutinin mutants
US20040057969A1 (en) Compositions containing stabilized hepatitis antigen and methods of their use
EP2827893B1 (en) Virus-like particles comprising a matrix protein from a plant enveloped virus and uses thereof
CA3133030C (en) Norovirus-like particles with improved stability
KR102677058B1 (ko) 식물 발현 바이러스유사입자를 이용한 바리과 신경괴사증 예방백신 조성물
US12467058B2 (en) Influenza virus-like particle production in plants
Yusibov et al. Plant viral expression vectors: history and new developments

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)